Mcl-1 downregulation has already been shown to sensitize cholangiocarcinoma cells to TRAIL-induced apoptosis [23] and CML cells towards treatment with imatinib [24]. The gene discussed is TNFSF10; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.